Management Consulting

Integrated Launch Planning

A fully coordinated, holistic approach

Benefit from Alira Health’s full spectrum of strategy and advisory services to ensure successful outcomes for all of your business stakeholders: patients, providers, payers, and suppliers.

Elevating industry best practices and innovation

Integrated launch planning (ILP) is recognized as an essential best practice. Alira Health provides full spectrum support to coordinate key launch deliverables in a transparent, collaborative way. This allows functions and markets across your organization to focus on the path towards launch in a more holistic, integrated way—a critical key to success.

The purpose of the ILP is not to replace functional launch plans—it’s to provide high-level leadership that delivers an integrated view of the whole picture. As your partner, Alira Health will highlight potential needs for analysis and inquiry if delays are anticipated.

Why choose Alira Health?

Whether your in-house teams are launching products across a multitude of therapeutic areas or you’re a BioTech company relying on third-party service providers, we will help you translating your launch strategy into a robust, executable plan.

Our experienced global team will actively engage with your organization to:

  • Structure your launch preparations and define appropriate launch governance
  • Meet with critical workstream teams to identify key deliverables and essential interdependencies
  • Deliver an integrated launch plan tool that is easy to update and provides customized status reports

Related news

Publications January 20, 2023
Insights on Market Access
To get her perspective on market access and what to expect in 2023, we spoke with Nerea Blanqué, Senior Vice President of Market Access and Pricing at Alira Health.
Market Access Medical Devices Pharma
Publications January 18, 2023
The State of Biopharma Funding
We spoke with Joris Pezzini, Executive Vice President of Biopharma, Alira Health, during the J.P. Morgan Healthcare Conference in San Francisco, which brings together investors and(...)
Biopharma Biotech Funding Pharma
Publications December 21, 2022
2022 Recap: Your Favorite Alira Health Publications
In 2022, the Alira Health team of scientists, strategists, economists, clinicians, and biostatisticians shared actionable insights, industry thought leadership, and leading-edge guidance(...)
Clinical Digital Health Market Access MedTech Pharma Regulatory
Publications November 8, 2022
Debate sobre los IPT en oncología: buscando puntos de mejora en la evaluación y acceso de los fármacos oncológicos en España
For our Spanish community members, we are glad to share the Debate on IPT in oncology: Looking for points of improvement in the evaluation and access of oncological drugs in Spain.
Oncology Pharma Spain
News October 4, 2022
Alira Health enhances its market access services through a strategic partnership with Centivis
Alira Health, a global healthcare advisory and technology company, announced a strategic partnership with Centivis AG, a boutique market access consulting agency, specializing in digital(...)
Digital Health Market Access MedTech Pharma Regulatory
News September 6, 2022
Alira Health Expands North American Capabilities with the Acquisition of Artisan Healthcare Consulting
The acquisition of Artisan strengthens and extends Alira Health’s Market Access and Management Consulting advisory practices in North America and globally.
Biotech Market Access Pharma Therapeutics
Publications August 25, 2022
Why—and When—to Use a CDMO
Pharmaceutical development companies of all sizes frequently outsource their Active Pharmaceutical Ingredient (API) manufacturing to CDMOs for various reasons. In this article, we explore(...)
CDMO Pharma Research and Development
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.